Kerala Ayurveda Limited has officially dispatched its postal ballot notice on December 19, 2025, to all eligible shareholders for seeking approval on three critical corporate matters through remote e-voting. The company completed the electronic dispatch of postal ballot notices along with explanatory statements to members whose email addresses are registered with the company or depository participants.

Postal Ballot Notice Details

The postal ballot notice was dispatched under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, following the board meeting held on December 17, 2025. The company has set the cut-off date as December 12, 2025, for determining eligible shareholders.

Three Special Resolutions for Approval

Shareholders will vote on three special resolutions through the remote e-voting process:

Asset Security Provisions: Approval for creation of charge or lien over company assets under Section 180(1)(a) of the Companies Act 2013, with borrowing limits not exceeding ₹250.00 crores including interest and other charges.

Financial Operations: Authorization for investments, loans, guarantees, letters of comfort, and security provisions under Section 186 of the Act, with limits up to ₹100.00 crores for enhanced financial flexibility.

Director Re-appointment: Formal approval for Ms. Shilpa Kiran Gududur's re-appointment as Independent Director for a second five-year term from February 15, 2026 to February 14, 2031.

Director Re-appointment Details

Ms. Shilpa Kiran Gududur brings over 23 years of professional experience to the board with qualifications including practicing Company Secretary credentials, Registered Valuer-SFA certification, and Insolvency Professional designation. Her educational background includes degrees from University of Mumbai, Bangalore University, and National Law School, Bangalore.

E-voting Process and Timeline

The e-voting facility will be available exclusively through CDSL platform for the specified period. Shareholders holding shares in demat form can vote through their depository accounts, while physical shareholders need to register with the company's e-voting system.

The company has appointed Mr. Pramod SM (FCS No.: 7834) or Mr. Biswajit Ghosh (FCS: 8750) from M/s. BMP Co. LLP as scrutinizers for conducting the postal ballot process in a fair and transparent manner.

Regulatory Compliance

Kerala Ayurveda Limited has confirmed compliance with all applicable provisions of the Companies Act 2013 and SEBI Listing Regulations. The postal ballot notice and related documents are available on the company's website at https://keralaayurveda.biz/ and will also be accessible through BSE Limited's website.

The results of the postal ballot will be declared within two working days from the conclusion of e-voting period and communicated to stock exchanges, depositories, and published on the company's website.

Kerala Ayurveda Ltd has established a new wholly owned subsidiary, Kerala Ayurveda Europe B.V., in Europe to expand its international operations and strengthen its presence in the European market. This move marks a significant step in the company's international expansion strategy.

Strategic European Expansion

The registration of Kerala Ayurveda Europe B.V. represents the company's commitment to establishing a direct presence in the European market. This subsidiary structure will enable Kerala Ayurveda to operate more effectively within the European regulatory framework and serve customers in the region more efficiently.

Subsidiary Details

The key parameters of this corporate development include:

Market Implications

The establishment of a European subsidiary indicates Kerala Ayurveda's strategic focus on international markets. By creating a local entity in Europe, the company can potentially benefit from:

• Enhanced market access and customer service
• Improved regulatory compliance within European markets
• Streamlined operations for European business activities
• Stronger local presence for brand building

This development aligns with the growing global interest in ayurvedic and traditional pharmaceutical products, positioning Kerala Ayurveda to capitalize on European market opportunities through its dedicated regional subsidiary.